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ABSTRACT  
Background: Chlorpheniramine is an antihistamine that is used in the treatment of rhinitis and other allergies. Objectives: The objectives of 
this research was to develop and evaluate transdermal patches for improved delivery of chlorpheniramine in infants using hypromellose and 
cassava starch composite polymers. Methods: Chlorpheniramine transdermal patches were formulated by solvent casting method using 
varying amounts of hypromellose (hydroxypropyl methylcellulose), cassava starch and polyethylene glycol 4000. The formulated transdermal 
patches were characterized by Fourier Transform Infra-red Spectroscopy (FT-IR), folding endurance, elongation breaking test, percentage 
moisture uptake/loss and ex vivo permeation studies. Results: The spectra showed no chemical interaction between the ingredients. The 
transdermal patches showed elastic qualities and high folding endurance. Patches with consistently high moisture uptake (around 40%) were 
observed to contain high concentration of cassava starch while those with higher amounts of HPMC lost more water (around 35%). The ex vivo 
study showed efficient permeation and flux for the target purpose. Conclusion: Transdermal patches may be used to deliver low dose 
chlorpheniramine drug through the skin possibly soft and thin infant skin.  
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INTRODUCTION 
Chlorpheniramine is a first generation, oral sedating 
antihistamine (H1-blocker) of the alkylamine class used in 
the treatment of rhinitis and other allergies. It is an 
anticholinergic antihistamine. The half-life in children is 
around 13 h 1, whereas in adults it is approximately 20 h and 
is mainly eliminated after metabolism to monodesmethyl 
and didesmethyl compounds 2. The drug is largely 
inactivated in the liver and the metabolites excreted in the 
urine. The continuous treatment of infants of these allergies 
may require frequent administration of chlorpheniramine 
and transdermal administration would provide a convenient, 
safer and more effective route with bypass of first-pass 
metabolism in liver. 
Transdermal drug delivery systems are self-contained, 
discrete dosage forms which are actually patches 3 that when 
applied to the intact skin, deliver any loaded drug through 
the skin at a controlled rate to the systemic circulation 4. This 
set-up allows a pre-calculated amount of drug to be 
delivered at pre-designed and reproducible rate through the 
skin 3. Transdermal drug administration is non-invasive and 
therefore avoids any interference with body barrier or 
disruption of physiological barriers such as the skin.  Influx 
of drug into the human blood system can be promptly 
interrupted simply by removal of the patch if toxicity is 
observed in any form such as reactions or discomfort. This 
mode of drug administration improves compliance. 
Chlorpheniramine is a low dose drug and the skin of infants 
is sufficiently tender, thin and weak to encourage passage of 
low dose drugs which explains the rational for engaging in 
this study. 
The objective of this research is to prepare, optimize and 
characterize transdermal patches for the delivery of 
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chlorpheniramine in infants using hypromellose and cassava 
starch composite polymers. 
MATERIALS AND METHODS 
Materials 
Chlorpheniramine (Juhel, Nigeria), HPMC (Qualikems, India), 
Cassava starch (extracted in Pharm Tech Lab, UNN), PEG 
4000, Propylene glycol, Tween 80 (Sigma Aldrich, USA). 
Methods 
Extraction of cassava starch 
Cassava starch was extracted in Pharmaceutical Technology 
laboratory, University of Nigeria, Nsukka. The tubers of 
Manihot utilissima (cassava) was peeled and reduced into 
small pieces. The reduced pieces of cassava tubers were 
soaked in distilled water for 48 h. After, it was washed and 
soaked in 0.1 M sodium metabisulphite solution for 24 h. 
Thereafter, the metabisulphite solution was washed off and 
pieces of cassava tubers ground/ blended to a pulp. The cell 
debris was removed by passing the slurry through a muslin 
cloth of 150 m aperture sieve size, with occasional passage 
of water for effective filtration. The starch was then allowed 
to settle and the supernatant decanted. The starch was 
suspended in 0.I N potassium hydroxide solution for 12 h. 
The solution was washed off completely and the starch was 
also suspended in 0.I N sulphuric acid solution for 12 h. The 
solution was effectively removed/ washed off and the settled 
starch washed with distilled water to remove impurities (e.g 
cyanide), tested for sulphates/sulphites, and dried at 40 °C 
for 6 h. The extracted starch was identified using established 
protocols. 
Preparation of chlorpheniramine transdermal patches  
Varying concentrations of HPMC, cassava starch, and PEG 
4000 were employed in the formulation of chlorpheniramine 
transdermal patches. Chlorpheniramine, propylene glycol 
and Tween 80 were used as fixed amounts. For the different 
batches (A-H), different quantities of the materials were 
weighed and measured as shown in Table 1.  
The cassava starch and HPMC were mixed in a 250 ml beaker 
dispersed in water (heated to 60°C) and stirred to obtain 
mucilage. It was further diluted with 20 ml of water. 
Propylene glycol, PEG 4000, Tween 80 and chlorpheniramine 
were dispersed in 10 ml of water, stirred and then added to 
the mucilage. The mucilage was diluted to 50 ml by making 
up with water, stirred and poured into a petri dish. The 
formulations were allowed to dry at room temperature after 
which they were stored for further use. 
 
 
Table 1: Formulation of different patches 
Materials Batch  
A 
Batch 
 B 
Batch 
 C 
Batch 
 D  
Batch  
E 
Batch  
F 
Batch  
G 
 Batch  
H 
Chlorpheniramine 176mg 176mg 176mg 176mg 176mg 176mg 176mg 176mg 
Cassava starch 1000mg 200mg 200mg 600mg 600mg 200mg 466.7mg 320mg 
HPMC 1600mg 2400mg 1600mg 2000mg 1600mg 2000mg 1866.7mg 2040mg 
PEG 4000 200mg 200mg 1000mg 200mg 600mg 600mg 466.7mg 440mg 
Propylene glycol 1ml 1ml 1ml 1ml 1ml 1ml 1ml 1ml 
Tween 80 0.2ml 0.2ml 0.2ml 0.2ml 0.2ml 0.2ml 0.2ml 0.2ml 
 
 
Characterization of transdermal patches  
Fourier transform infrared spectroscopy (FT-IR) 
FT-IR was used to investigate any chemical interaction 
between chlorpheniramine maleate and transdermal patch 
excipients. Sufficient quantities of pure chlorpheniramine 
maleate, HPMC, cassava starch, polyethylene glycol 4000 
and the formulated transdermal patches were scanned over 
a wavelength range of 4000 to 650 cm-1 at a resolution of 
4cm-1 in a FT-IR instrument (Agilent Technologies, USA). The 
system was operated in the transmission mode. Samples 
were placed on the sample stage and 100 N force applied for 
scanning.    
Physical appearance and properties 
All the formulated patches were inspected for clarity, colour, 
and smoothness. Also other organoleptic properties such as 
odour was also observed.  
Folding endurance and percentage elongation break test 
Folding endurance of patches/ films was determined 
manually by folding a 1cm2 strip of each patch repeatedly at 
the same place on the patch until a breaking point is 
reached.  
The number of times that the patch was folded at the same 
place without breaking or cracking was taken as the value 
for the folding endurance. 
The percentage elongation break was determined by 
recording the length just before the break point, the 
percentage elongation can be determined from Equation 1:  
Elongation % = 
     
  
     ------------------------1 
Where L1 and L2 are the final and initial lengths of each strip.  
Percentage moisture uptake and loss of patches     
The percentage moisture uptake of the patches was 
determined using static methods involving saturated salt 
solutions. For moisture uptake, weighed patches were 
placed in desiccators containing 100 ml of saturated solution 
of potassium chloride (84% relative humidity RH). At 24 h 
intervals for 4 days, the patches were removed and weighed.  
The percentage moisture uptake was calculated as one 
hundred times the ratios of the difference between final and 
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initial weights to the initial weights of the patches (Equation 
2):  
Percentage moisture uptake= 
            –             
             
     --- 2 
For percentage moisture loss, the weighed patch samples 
were kept in a desiccator containing 20g of anhydrous 
calcium chloride. At 24 h intervals for 4 days, the patches 
were removed and weighed repeatedly. The percentage 
moisture loss was calculated from the difference between 
initial and final weight with respect to initial weight as 
presented in Equation 3: 
Percentage moisture loss= 
              –            
             
      ---- 3 
Ex vivo skin permeation studies  
Ex vivo skin permeation studies was performed using a 
magnetic stirrer-beaker assembly. The patches were 
sandwiched between two layers of the excised skin while 
sealing the edges of the layers. The skin and the sandwiched 
patch were placed in a cylindrical basket which was 
suspended in a beaker containing 100ml of phosphate buffer 
saline (pH 7.4). The assembly was fixed in a magnetic stirrer 
apparatus and the receptor medium continuously stirred 
using magnetic beads at 50 rpm, while the temperature was 
maintained at 37+ 1°C. Samples were withdrawn at 1 h 
intervals for 5 h and analyzed for drug content using 
spectrophotometer at 252 nm. The medium was replenished 
with equal volume of PBS, pH 7.4, after each sample 
withdrawal. The amount of drug permeated per square 
centimeter of patches was plotted against time.  
The permeation data was analyzed by determining the flux 
and permeability coefficient of the drug. The flux (µg cm-2 h-
1) of chlorpheniramine maleate was calculated from the 
slope of the plot of the cumulative amount of 
chlorpheniramine permeated per cm2 of skin at steady state 
against time using linear regression analysis. The steady-
state flux (J) was determined from the relationship in 
Equation 4: 
J = 
  
   
              ----------------------- 4 
Where Q indicates the quantities of substances crossing the 
rat skin, A is the area of the rat skin exposed and t is the time 
of exposure. 
The permeability coefficients are obtained from the steady-
state flux values using Equation 5: 
P =    ⁄       
    ----------------------------5 
Where P is the permeability coefficient, Co is the initial drug 
concentration in the donor compartment and J represents 
the steady-state flux obtained from Equation 4. Co is the 
concentration of drug in the patch. 
RESULTS AND DISCUSSION 
Organoleptic properties of the transdermal patches 
The patches were smooth, opaque and odourless. The 
patches possess desirable physical attributes which would 
facilitate its general acceptance and use. 
Fourier transform infrared spectroscopy (FT-IR) 
The FT-IR (Figs. 1-6) showed that there was no drug-
excipient interaction since all the bands in the spectra 
represented functional groups in the individual component. 
The FT-IR spectra of the components showed methyl, 
hydroxyl and ether bond stretching while amine bond 
stretch was also observed for chlorpheniramine. The spectra 
of formulated patches were also seen to have the bands 
representing these functional group. 
  
 
Figure 1: FT-IR Spectra for Cassava Starch 
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Figure 2: FT-IR Spectra for Chlorpheniramine 
 
Figure 3: FT-IR Spectra for PEG 4000 
 
Figure 4: FT-IR Spectra for HPMC 
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Figure 5: FT-IR Spectra for Batch A 
 
Figure 6: FT-IR Spectra for Batch F 
 
 
Folding endurance and breaking elongation  
The folding endurance of the patches were determined with 
patches C, E, F and G having the highest folding endurance of  
> 500 and patch A showing the least folding endurance of 89. 
Batches C, E, F and G have higher PEG concentration. This 
shows that differences in concentration of the constituents 
can affect the final mechanical property of the product. The 
combined effect of HPMC as film-former and PEG as 
plasticizer may have facilitated this flexibility attribute. 
Hydrophilic compounds such as polyethylene glycol has been 
used as plasticizers in starch-based films to improve the 
physico-mechanical and barrier properties of these products. 
The brittleness and rigidity of mixtures containing starch 
(after storage), usually facilitated by recrystallization of 
starch molecules, causes a major problem 5. The 
biodegradable PEG plasticizer may have occupied 
intermolecular spaces between polymer chains, changed the 
3D-molecular organization, reduced the energy required for 
molecular motion and improved hydrogen bonding between 
chains. The results of folding endurance are presented in 
Table 2. The percentage elongation break test measures the 
ability of the formulated patches to withstand the mechanical 
stress of pull. The formulated patches (A-H) all showed 
elasticity on elongation. 
Percentage Moisture Uptake and Loss 
The percentage moisture uptake (Fig 7) with time (in days) 
of the formulated patches showed that patch A had the 
highest uptake and patch B had the least moisture uptake. 
Patch A with high concentration of cassava starch absorbed 
more moisture than other patches while batches D and B 
with high amounts of HPMC showed low moisture uptake 
probably because the HPMC had already entrapped and 
bonded relatively large quantities of water during 
production inhibiting further attraction of moisture. 
Moisture content would affect properties such as adhesion 
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and stability (especially since moisture supports microbial 
growth which causes degradation). Physical integrity of the 
product would also be affected. 
For moisture loss (Fig 8), patches B, D, F and H with higher 
HPMC concentration showed higher moisture losses. This is 
because it was relatively easier for these batches to loss 
water under dry atmosphere than to absorb more under high 
relative humidity.  
Percentage moisture uptake and loss were mostly around 0-
40% and 15-45%, respectively. The nature and strength of 
bonding of all the constituents in the transdermal patches or 
films would affect the rate and extent of drug release from 
these automated devices. 
Table 2: Folding endurance of the transdermal patches 
Batch Folding Endurance 
A 89 
B 230 
C >500 
D 100 
E >500 
F >500 
G >500 
H 200 
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Figure 7: Moisture uptake profile of patches 
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Figure 8: Moisture loss profile of transdermal patches  
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Ex vivo Permeation Studies 
From the results obtained (Fig. 9), batch G showed the 
highest chlorpheniramine permeation through the excised 
rat skin. This batch is at the centre point of the design of 
experiment and contains the variable components as 
follows; cassava starch 0.47g, HPMC 1.87g and PEG 4000 
0.47g. This shows the need for a balance of these 
components and an optimal mixture is required for 
maximum permeation of chlorpheniramine. Batch E showed 
the lowest chlorpheniramine permeation and independent 
variables present are cassava starch 0.6g, HPMC 1.6g and 
PEG 4000 0.6g. The result showed that improved 
permeation may be achieved if the difference between HPMC 
and either or both of cassava starch or/and PEG 4000 is 
more than 1g or a factor of 2.67. Most of the films showed a 
sustained, steady release and permeation of 
chlorpheniramine. The use of HPMC created a network that 
is highly hydrophilic allowing drug release. The responses 
obtained showed that combinations around the centre point 
of the centroid design space produced films with improved 
drug release and permeation. It has been typically observed 
that addition of hydrophilic component to an insoluble film-
former usually improves the drug release rate 6. Usually the 
dissolution of the aqueous soluble fraction of the film or 
patch facilitate drug release and permeation and may create 
channels or pores which decrease mean diffusion path 
length of the drug molecule being released into dissolution 
medium 7. 
Batches B and D with relatively high HPMC and low PEG 
showed a rising permeation profile probably because the 
lower amount of plasticizer allowed gradually increasing 
release and permeation. The transdermal patches exhibited 
controlled drug delivery for the release and permeation of 
low dose of chlorpheniramine through the excised rat skin 
over a prolonged period of time. Furthermore the metered 
dose released over time showed that similar transdermal 
profile can be achieved for infant dose. 
Flux was obtained as slope of linear relationship between 
amount of drug permeated per unit surface area and time. 
The flux and permeability coefficients are shown in Table 3. 
The range of these important permeation parameters are as 
follows; Flux was 7.40-15.93 µg/cm2h and permeability 
coefficient was 0.000561-0.001207 cm/h. These data reflect 
the possibility of applying the formulation for tailored infant 
doses. The unique nature of the modified ex vivo study with 
film/patch sandwiched between skin surfaces allowed 
diffusion of drug to occur from the two sides of the 
film/patch with increased initial drug release. The values of 
the steady state flux or rate of drug permeation showed that 
the transdermal system may be valuable in minimizing the 
sedating effect of the drug by only providing small gradual 
increments in systemic drug concentrations. The presence of 
polysorbates in the formulation enhances drug permeation 
by opening epidermal pores and tight junctions. Some 
surface-active agents have been shown to affect tight 
junction permeability 8. Previous studies have shown that 
mixtures of hydrophilic polymers and cassava starch can 
form suitable film-formers for improved transdermal drug 
delivery 9 and HPMC have been effectively used to formulate 
transdermal films of low dose drugs 9, 10.  
 
 
 
 
 
 
0
20
40
60
80
100
120
0 1 2 3 4 5 6
A
m
o
u
n
t 
o
f 
d
ru
g 
p
er
m
ea
te
d
 p
er
 u
n
it
 s
u
rf
ac
e 
ar
ea
 
o
f 
ra
t 
sk
in
 (
u
g
/c
m
2
) 
Time (h) 
Figure 9: Chlorpheniramine permeation profile 
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Table 3: Flux and Permeability Coefficient values for chlorpheniramine transdermal films 
Batches Flux (µg/cm2h) Permeability coefficient (cm/h) 
A 15.11 0.001145 
B 15.04 0.001139 
C 14.39 0.001090 
D 14.37 0.001089 
E 7.40 0.000561 
F 12.93 0.000980 
G 15.93 0.001207 
H 12.73 0.000964 
 
 
CONCLUSION 
The transdermal route has been shown to be effective, non-
invasive means for the administration of Chlorpheniramine 
in allergy-related conditions. Hypromellose and cassava 
starch function effectively as film formers for the formulation 
of the transdermal patches. Different combinations of 
materials produce patches with varied physical, mechanical 
and drug permeation properties. Transdermal patches can 
be effectively used to deliver controlled doses of 
chlorpheniramine through the skin for systemic actions for 
prolonged duration and may be useful in Paediatric 
Medicine. 
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